Global Stereotactic-guided Biopsy Instrument Market By Type (Needle-based Biopsy Instruments, Localization Wires, and Procedure Trays), By Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, and Prostate Biopsy), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 137469
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Stereotactic-guided Biopsy Instrument Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global stereotactic-guided biopsy instrument market is segmented on the basis of Type, Application, and geography.
The Worldwide market for Stereotactic-guided Biopsy Instrument Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Stereotactic-guided Biopsy Instrument Market Scope:
By type, the market is segmented into Needle-based Biopsy Instruments, Localization Wires, and Procedure Trays. By Application, the market is divided into Breast Biopsy, Lung Biopsy, Colorectal Biopsy, and Prostate Biopsy.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include C. R. Bard inc. (U.S.), Becton Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products inc. (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD inc. (U.S.), and Medtronic plc (Ireland).Key Market Segments
Type
Needle-based Biopsy Instruments
Localization Wires
Procedure TraysApplication
Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate BiopsyKey Market Players included in the report:
C. R. Bard inc. (U.S.)
Becton Dickinson and Company (U.S.)
Cook Group Incorporated (U.S.)
Devicor Medical Products inc. (Leica Biosystems) (Germany)
Argon Medical Devices (U.S.)
B. Braun Melsungen AG (Germany)
B. Braun Melsungen AG (Germany)
Olympus Corporation (Japan)
Boston Scientific Corporation (U.S.)
FUJIFILM Holdings Corporation (Japan)
INRAD inc. (U.S.)
Medtronic plc (Ireland)Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Stereotactic-guided Biopsy Instrument Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Stereotactic-guided Biopsy Instrument Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Stereotactic-guided Biopsy Instrument Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Stereotactic-guided Biopsy Instrument Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Stereotactic-guided Biopsy Instrument Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Stereotactic-guided Biopsy Instrument Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Stereotactic-guided Biopsy Instrument sub-markets, depending on key regions (various vital states).
To analyze Stereotactic-guided Biopsy Instrument Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Stereotactic-guided Biopsy Instrument Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
Primary worldwide Stereotactic-guided Biopsy Instrument Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Stereotactic-guided Biopsy Instrument Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Stereotactic-guided Biopsy Instrument Market Overview3.1. Stereotactic-guided Biopsy Instrument Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Stereotactic-guided Biopsy Instrument Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Stereotactic-guided Biopsy Instrument Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Needle-based Biopsy Instruments4.4. Localization Wires
4.5. Procedure Trays5. Global Stereotactic-guided Biopsy Instrument Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Stereotactic-guided Biopsy Instrument Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Breast Biopsy5.4. Lung Biopsy
5.5. Colorectal Biopsy
5.6. Prostate Biopsy6. Global Stereotactic-guided Biopsy Instrument Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Stereotactic-guided Biopsy Instrument Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Stereotactic-guided Biopsy Instrument Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Stereotactic-guided Biopsy Instrument Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Stereotactic-guided Biopsy Instrument Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Stereotactic-guided Biopsy Instrument Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Stereotactic-guided Biopsy Instrument Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. C. R. Bard inc. (U.S.)7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Becton Dickinson and Company (U.S.)7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Cook Group Incorporated (U.S.)7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. Devicor Medical Products inc. (Leica Biosystems) (Germany)7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. Argon Medical Devices (U.S.)7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. B. Braun Melsungen AG (Germany)7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. B. Braun Melsungen AG (Germany)7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. Olympus Corporation (Japan)7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. Boston Scientific Corporation (U.S.)7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments 7.12. FUJIFILM Holdings Corporation (Japan)7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments 7.13. INRAD inc. (U.S.)7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments 7.14. Medtronic plc (Ireland)7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample